Business Wire - Andrx’ Cardizem CD Launched in Canada
Thursday, November 27th, 2008 Business Editors/Health & Medical Writers
FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–March 12, 2001
Andrx Corporation — Andrx Group (Nasdaq:ADRX) today announced that Health Canada, the Canadian health authority, has approved the sale throughout Canada of all four strengths of its bioequivalent version of Cardizem(R) CD. Licensed to Rhoxalpharma, Inc., this product, marketed as Rhoxal-diltiazem CD, has already been launched. Diltiazem CD remains one of the largest selling pharmaceuticals i…
